BioCorRx Inc. BICX

Full chart Compare

Set alert

0.20 USD 0.00 (+0.00%)

At closeNov 9, 2026, 4:00 PM EST

0.201 Day range 0.201

0.152 52-week range 1.28

YTD: -30.93%
1 year: -54.42%

News

1 month ago defenseworld.net Biocorrx Inc. (OTCMKTS:BICX) Stock Short Interest Drops 44.3% Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 10,083…
1 month ago defenseworld.net Short Interest in Biocorrx Inc. (OTCMKTS:BICX) Expands By ∞ Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 18,093 shares, an…
2 months ago defenseworld.net Biocorrx Inc. (OTCMKTS:BICX) Short Interest Update Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 543 shares, a decline of 68.8% from the…
3 months ago defenseworld.net Biocorrx Inc. (OTCMKTS:BICX) Short Interest Update Biocorrx Inc. (OTCMKTS:BICX - Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,741 shares, an…
7 months ago defenseworld.net Head-To-Head Analysis: Biocorrx (OTCMKTS:BICX) and IceCure Medical (NASDAQ:ICCM) IceCure Medical (NASDAQ: ICCM - Get Free Report) and Biocorrx (OTCMKTS:BICX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two…
7 months ago defenseworld.net GoodRx (NASDAQ:GDRX) versus Biocorrx (OTCMKTS:BICX) Critical Comparison Biocorrx (OTCMKTS:BICX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based…
8 months ago defenseworld.net Biocorrx (OTCMKTS:BICX) Stock Price Crosses Above 50 Day Moving Average – Here’s What Happened Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.32 and traded as high as…
10 months ago defenseworld.net Biocorrx (OTCMKTS:BICX) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell? Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.38 and traded as low as…
11 months ago globenewswire.com BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
11 months ago defenseworld.net Biocorrx (OTCMKTS:BICX) vs. CVS Health (NYSE:CVS) Critical Survey Biocorrx (OTCMKTS:BICX - Get Free Report) and CVS Health (NYSE: CVS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the…
11 months ago globenewswire.com Diamond Equity Research Releases Update Note on BioCorRx®, Inc. (OTCQB: BICX) New York, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update report on BioCorRx®, Inc.…
1 year ago globenewswire.com Diamond Equity Research Initiates Coverage on BioCorRx®, Inc. (OTCQB: BICX) New York, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has initiated coverage of BioCorRx®, Inc. (OTCQB:…
2 years ago globenewswire.com BioCorRx Reports Business Update for the Second Quarter of 2024 ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today…
2 years ago globenewswire.com BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related disorders,…
2 years ago globenewswire.com BioCorRx Reports Business Update for 2023 ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and…
2 years ago globenewswire.com BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related…
2 years ago globenewswire.com BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors ANAHEIM, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and…
2 years ago globenewswire.com BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and…
2 years ago globenewswire.com BioCorRx Reports Business Update for the Third Quarter of 2023 ANAHEIM, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and…
7 years ago benzinga.com Stocks That Hit 52-Week Lows On Monday